Chen, Qiyu (1972-04-30) 陳啟宇
Supervisory
Main board
|
|
Organisation |
Position |
From |
Until |
Total
Return |
CAGR
total
return |
CAGR
relative
return |
| 1 |
* |
BabyTree Group |
NEDNon-Executive Director |
2018-06-11 |
2020-06-30 |
-78.17% |
-61.58% |
-61.02% |
| 2 |
|
Beijing Sanyuan Foods Co., Ltd. |
DirDirector |
2015-03 |
|
|
|
|
| 3 |
|
Dian Diagnostics Co., Ltd. |
DirDirector |
2010-05 |
2019-02 |
|
|
|
| 4 |
* |
FOSUN INTERNATIONAL LIMITED |
EDExecutive Director |
2015-07-10 |
2017-03-28 |
-31.50% |
-19.78% |
-21.02% |
|
|
|
Co-PresCo-President |
2017-03-28 |
2020-02-21 |
-0.92% |
-0.32% |
-7.36% |
|
|
|
Co-CEOCo-Chief Executive Officer |
2020-02-21 |
|
-51.06% |
-15.66% |
-10.49% |
| 5 |
|
Maxigen Biotech Inc. |
DirDirector |
2015-12 |
2017-11 |
|
|
|
| 6 |
|
MIRACLE NOVA (UK) LIMITED |
DirDirector |
2018-06-08 |
|
|
|
|
| 7 |
|
PLATA CROSS (UK) LIMITED |
DirDirector |
2015-06-03 |
2022-09-30 |
|
|
|
| 8 |
* |
SHANGHAI FORTE LAND CO., LTD. |
NEDNon-Executive Director |
2008-10-27 |
2011-05-13 |
282.58% |
70.25% |
24.41% |
| 9 |
* |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
Pres, Vice ChPresident, Vice Chairman |
|
U |
|
|
|
|
|
|
ChChairman |
2005-05-10 |
2020-10-29 |
236.16% |
16.37% |
10.66% |
|
|
|
NEDNon-Executive Director |
2020-10-29 |
|
-58.84% |
-22.35% |
-18.42% |
| 10 |
* |
Shanghai Henlius Biotech, Inc. |
DirDirector |
2013-01-15 |
2018-12-08 |
|
|
|
|
|
|
NED, ChNon-Executive Director, Chairman |
2018-12-08 |
2021-11-30 |
-38.83% |
-20.17% |
-18.70% |
|
|
|
NEDNon-Executive Director |
2021-11-30 |
|
-45.12% |
-21.94% |
-16.70% |
| 11 |
* |
SINOPHARM GROUP CO. LTD. |
NEDNon-Executive Director |
2010-05-31 |
2013-11-08 |
-31.85% |
-10.55% |
-16.60% |
|
|
|
NED, Vice ChNon-Executive Director, Vice Chairman |
2013-11-08 |
|
24.28% |
2.09% |
0.75% |
|
|
Average |
|
|
|
|
-7.60% |
-12.23% |
Some data are hidden to fit your display. Rotate?
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until
the earliest of the end date, the resignation/removal date and the last trading date.
CAGR is the annualised return and is not shown for periods under 180 days.
Relative returns are to the Tracker Fund
of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
* = is or was HK primary-listed
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy
Back to top
